The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2018

Filed:

Oct. 21, 2015
Applicant:

Lanzatech New Zealand Limited, Skokie, IL (US);

Inventors:

Bjorn Daniel Heijstra, Skokie, IL (US);

Sean Dennis Simpson, Skokie, IL (US);

Nicholas Bourdakos, Skokie, IL (US);

Jason Carl Bromley, Skokie, IL (US);

Kai-Ming Yap, Skokie, IL (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/02 (2006.01); G01N 30/02 (2006.01); G01N 30/88 (2006.01); C12M 1/107 (2006.01); C12M 1/00 (2006.01); C12M 3/00 (2006.01); C12M 1/34 (2006.01); G01N 30/46 (2006.01); G01N 30/00 (2006.01); C12P 7/06 (2006.01); G01N 30/86 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/02 (2013.01); C12M 21/04 (2013.01); C12M 21/12 (2013.01); C12M 23/44 (2013.01); C12M 29/18 (2013.01); C12M 41/00 (2013.01); C12M 41/12 (2013.01); C12M 41/26 (2013.01); C12M 41/34 (2013.01); G01N 30/02 (2013.01); G01N 30/88 (2013.01); C12P 7/065 (2013.01); G01N 30/462 (2013.01); G01N 30/8658 (2013.01); G01N 2030/0095 (2013.01); Y02E 50/343 (2013.01);
Abstract

Apparatuses and associated methods are described for the efficient evaluation of C1-containing substrates, and especially for such evaluation conducted locally, or on-site, at a prospective facility for implementation of a biological conversion process for desired end product using a C1 carbon source. The exact composition of a given, industrial C1-containing substrate, as well as the range in composition fluctuations, are generally difficult to reproduce at a remote facility (e.g., a laboratory or a pilot-scale or demonstration-scale process), as required for the accurate prediction/modeling of commercial performance to justify large capital expenditures for commercial scale-up.


Find Patent Forward Citations

Loading…